<< Back to News

System Formulary Update
Multivitamins

Situation

The multivitamins class review and formulary standardization was approved at the January 2022 System Pharmacy and Therapeutics Committee meeting.

Background

The following medications were reviewed: general multivitamins, multivitamins with minerals, prenatal multivitamins, cystic fibrosis multivitamins, geriatric multivitamins, and pediatric multivitamins

Assessment/Recommendation

Changes effective: Tuesday, March 1, 2022

System P&T voted to include the following products on the UNC Health Medication Formulary:

• Multivitamin infusion (no changes to current practice)
• Multivitamin with Minerals
  • Tablet, Oral: Thera-M, Thera-M Plus, Therems-M
  • Liquid, Oral: Centrum (237 mL), Multi-vite (237 mL)
• Cystic Fibrosis Vitamin
  • Softgel, Oral: MVW Complete D1500, D3000, D5000
  • Liquid, Oral: MVW Pediatric drops (30 mL bulk bottle)
• Pediatric Multivitamin
  • Chewable Tablet, Oral: Flintstones with Iron
  • Liquid, Oral: Poly-Vi-Sol drops (50 mL bulk bottle, 0.25 mL unit-dose syringe, 0.5 mL unit-dose syringe)
  • Liquid, Oral: Poly-Vi-Sol with Iron drops (50 mL bulk bottle, 0.25 mL unit-dose syringe, 0.5 mL unit-dose syringe)
• Prenatal Multivitamin
  • Tablet, Oral: PrePlus

Note: Stock of these formulary products may vary at individual entities

As a result, the following products will be removed from the UNC Health Medication Formulary

• All other multivitamins with minerals
• All other cystic fibrosis multivitamins
• All other pediatric multivitamins
• All other prenatal multivitamins

Non-formulary orders will be converted according to the following therapeutic interchange: